These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8470424)

  • 1. Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule.
    Newman RW; Jennings R; Major DL; Robertson JS; Jenkins R; Potter CW; Burnett I; Jewes L; Anders M; Jackson D
    Vaccine; 1993; 11(4):400-6. PubMed ID: 8470424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.
    Wood JM; Oxford JS; Dunleavy U; Newman RW; Major D; Robertson JS
    Virology; 1989 Jul; 171(1):214-21. PubMed ID: 2741341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and antigenic analysis using monoclonal antibodies of a series of of influenza A (H3N2) and (H1N1) virus reassortants.
    Oxford JS; Corcoran T; Newman R; Major D; Schild GC
    Vaccine; 1986 Mar; 4(1):9-14. PubMed ID: 3962452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.
    Kodihalli S; Justewicz DM; Gubareva LV; Webster RG
    J Virol; 1995 Aug; 69(8):4888-97. PubMed ID: 7609057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host cell-mediated variation in H3N2 influenza viruses.
    Katz JM; Naeve CW; Webster RG
    Virology; 1987 Feb; 156(2):386-95. PubMed ID: 3811239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the antibody response of mice and humans after immunization with potential influenza virus A (H1N1) vaccines.
    Poumbourios P; Oxford JS; Jackson DC
    Immunol Cell Biol; 1993 Feb; 71 ( Pt 1)():13-25. PubMed ID: 7679664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genomic and antigenic analysis of strains of influenza A virus (H1N1) isolated in 1982-1983: approaches to the choice of the optimal vaccine strain].
    Akopova II; Klimov AI; Unanov SS; Krasnova VP; Grinbaum EB
    Vopr Virusol; 1986; 31(3):288-92. PubMed ID: 2429448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus.
    Robertson JS; Bootman JS; Newman R; Oxford JS; Daniels RS; Webster RG; Schild GC
    Virology; 1987 Sep; 160(1):31-7. PubMed ID: 3629978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
    Kyriakis CS; Gramer MR; Barbé F; Van Doorsselaere J; Van Reeth K
    Vet Microbiol; 2010 Jul; 144(1-2):67-74. PubMed ID: 20116942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 1. Preparation of antibodies and in vitro studies.
    Haaheim LR; Schild GC
    Acta Pathol Microbiol Scand B; 1979 Oct; 87(5):291-9. PubMed ID: 93399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin.
    Webster RG; Fynan EF; Santoro JC; Robinson H
    Vaccine; 1994 Dec; 12(16):1495-8. PubMed ID: 7879412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants.
    Kilbourne ED; Johansson BE; Moran T; Wu S; Pokorny BA; Xu X; Cox N
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1311-6. PubMed ID: 8336120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.
    Katz JM; Webster RG
    J Infect Dis; 1989 Aug; 160(2):191-8. PubMed ID: 2760480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.